USANA Q2 FY26 turns to net loss of $21.4 million; net sales fall 5% to $223 million

• USANA Health Sciences posted a net loss of $21.4 million, swinging from profit, on net sales down 5% to $223 million.
• GAAP diluted EPS fell to a loss of $1.16; results included an estimated preliminary non-cash goodwill impairment charge of $29.1 million.
• Adjusted EBITDA slipped 9% to $27.8 million; Core Nutritional active customers fell 8% to 384,000.
• Hiya net sales dropped 17% to $28 million; active monthly subscribers fell 17% to 166,000 amid a challenging digital marketing environment.
• USANA cut fiscal 2026 consolidated net sales guidance to $910 million, lowering Hiya to $125 million and Rise Wellness to $35 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608041605BIZWIRE_USPR_____20260804_BW653227) on August 04, 2026, and is solely responsible for the information contained therein.